title: Is it time to revise linezolid doses in peritoneal dialysis patients? A case series.
authors.affiliation: Department of Infectious Diseases, L. Sacco University Hospital, Milan, Italy cristina.gervasoni@unimi.it.
authors.forename: Cristina
authors.initials: C
authors.lastname: Gervasoni
authors.affiliation: Unit of Nephrology and Dialysis, Degli Infermi Hospital, Biella, Italy.
authors.forename: Roberto
authors.initials: R
authors.lastname: Bergia
authors.affiliation: Unit of Clinical Pharmacology, L. Sacco University Hospital, Milan, Italy.
authors.forename: Valeria
authors.initials: V
authors.lastname: Cozzi
authors.affiliation: Clinical Pharmacology Unit, CNR Institute of Neuroscience, Department of Biomedical and Clinical Sciences, L. Sacco University Hospital, Università di Milano, 20157 Milan, Italy Scientific Institute IRCCS E. Medea, 23842 Bosisio Parini, Italy.
authors.forename: Emilio
authors.initials: E
authors.lastname: Clementi
authors.affiliation: Unit of Clinical Pharmacology, L. Sacco University Hospital, Milan, Italy.
authors.forename: Dario
authors.initials: D
authors.lastname: Cattaneo
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001424:Bacterial Infections / Q000150:complications / Q000209:etiology / Q000517:prevention & control; D016903:Drug Monitoring; D005260:Female; D006801:Humans; D000069349:Linezolid / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis / Q000009:adverse effects; D013921:Thrombocytopenia / Q000175:diagnosis / Q000209:etiology
chemical_list: D000900:Anti-Bacterial Agents; D000069349:Linezolid